Early skeleton map reveals how bones form in humans
The first ‘blueprint’ of human skeletal development reveals how the skeleton forms, shedding light on the process of arthritis, and highlighting cells involved in conditions that affect skull and bone growth.
Mapping 1.6 million gut cells to find new ways to treat disease
By combining 25 datasets, researchers have created the largest cohesive cell atlas of the human gut and uncovered a new way that stomach cells may play a role in Inflammatory Bowel Disease.
Shining a light on the life sciences
The OBN Awards struck an optimistic tone as the best of the UK’s life sciences industry was celebrated
Beaver Scouts design air quality superheroes in an educational talk on pollution
Youngsters were empowered to design air quality superheroes when South Cambridgeshire District Council held its first pollution awareness talk in the community.
Chris Dunn shortlisted as a Top UK Business Adviser
Chris Dunn has been shortlisted for the UK’s Top Business Advisers Awards. Chris who delivers consulting, coaching, and mentoring services to help entrepreneurs grow their business was picked from hundreds of advisers from around the UK for his outstanding work in business development.
Volunteer hospice drivers recognised by Hunts Forum 2024 Volunteer Awards
Volunteer drivers Edwin and Duncan receive Hunts Forum 2024 Volunteer Awards.
Large-area scanning for high-speed AFM: latest developments announced
Prior Scientific's Queensgate and NPL revealed their latest breakthrough at Euspen's Special Interest Conference: Precision Motion Systems and Control in November.
Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projectsCOPD management: a critical look at gaps in pharmaceutical innovation
Chronic Obstructive Pulmonary Disease (COPD) presents a major global health challenge, marked by chronic respiratory decline and frequent exacerbations. Despite advances in treatment, comprehensive management strategies remain limited, revealing significant gaps in patient care.
The EpiCentre is working with Microsoft to support innovative early-stage businesses
Oxford Innovation Space that manages The EpiCentre at Haverhill and Microsoft have announced that they are working together to support the growth of innovative early-stage businesses.
CrestOptics and Tomocube partner to advance 3D imaging with new multimodal imaging platform
First commercially available spinning-disk confocal holotomographic instrument, enabling advanced 3D imaging with fluorescence-based detection New system showcased at SPAOM24 (20th-22Tagomics announces a multiomic profiling co-marketing agreement with Agilent
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis
Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line
Strategic agreement will accelerate the manufacturing of fully human multispecific therapies for chronic retinal diseases with high unmet need using Asimov’s CHO Edge System
Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics
First-in-class steroid-toxicity outcome assessments licensed by argenx to support development of novel steroid-sparing therapeutics for autoimmune diseases
Your silent audience: why focusing on vanity metrics can lead you astray
When it comes to social media, it’s natural to fixate on likes, comments, and shares. We’ve all been there – watching the numbers tick up (or down) can be addictive! But these ‘vanity metrics’ are just one part of a much bigger picture.
Cambridge Index advances 0.3%
The Cambridge Index rose 63.7 points or 0.3% to close at 21,971.7, as seven out of the top ten index heavyweights posted weekly gains in their share price.
OBITUARY: Peter Cowley, celebrated technology entrepreneur and serial investor
Peter Cowley, celebrated entrepreneur and serial investor, passed away peacefully at his home in Cambridge on Saturday November 16th, surrounded by his family. He was 69.
Nominations open to celebrate ARU alumni success
Members of the public can nominate Anglia Ruskin graduates in seven categories.
Free trees for South Cambridgeshire towns and villages
Trees are being offered to parish councils across the district to create habitats and food for wildlife, while also playing a crucial role in the battle against climate change.
Cambridge MP backs youth empowerment with Inspire 2 Ignite
On Friday, 22 November, Cambridge MP Daniel Zeichner attended a special drop-in event for young people hosted by Inspire 2 Ignite at The Junction, Cambridge. Activities included a DJ workshop, where participants aged 12-24 learnt the basics of music mixing. The session also featured Curious Conversation Blocks, interactive tools designed to spark meaningful discussions, and a presentation by…
AA Thornton joins forces with Venner Shipley
Leading intellectual property firm AA Thornton is joining forces with Venner Shipley. From 1 December, the combined firm, with a headcount totalling 230 people, will operate under the Venner Shipley name.
40% discount on Carbon Literacy and AI short courses at Cambridge Marketing College
Cambridge Marketing College have a range of November offers! Get a 40% discount on Carbon Literacy and AI short courses and a 15% discount on CIM qualifications or CIM modular awards.
Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis
Paper in the European Journal of Medicinal Chemistry discloses the optimisation process leading to the selection for development of ETD001, an inhaled ENaC blocker with a best-in-class profile ETD001 commenced Phase 2 clinical study in people with cystic fibrosis in JulThe importance of choosing sustainable accommodation for winter travel
Winter is a time for cosy getaways, snowy adventures, and festive experiences, but it’s also a season that puts added pressure on the environment. Increased energy use for heating, high water demand, and waste generation can make winter travel a challenging time to be eco-friendly. One of the most impactful ways to reduce your environmental footprint during the winter months is by choosing…